# Ganymed Robotics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/ganymed-robotics

- Industry: Medical Devices & Equipment
- Headquarters: Paris, France
- Website: www.ganymedrobotics.com
- Total disclosed funding: $37M
- Latest round: Series B (Jan 4, 2023)
- Investors on record: 6

## About

Based in France, Ganymed Robotics SAS specializes in designing advanced robotic technologies aimed at enhancing orthopedic surgeries, particularly joint replacement procedures, to improve surgical precision and patient outcomes.Ganymed Robotics SAS is focused on developing robotic solutions for the orthopedic sector. Founded in 2018 in Paris, France, the company has completed 6 deals, with its most recent funding round occurring on January 4, 2023. This round was a Venture Debt funding of EUR 1 million led by Bpifrance, contributing to a total amount raised of EUR 14 million.Ganymed Robotics specializes in the development of advanced robotic technologies specifically tailored for the orthopedic sector. Their primary offerings focus on enhancing the precision and effectiveness of joint replacement surgeries, thereby improving patient outcomes and the overall experience for surgeons. The company’s solutions are designed to streamline surgical workflows, reduce recovery times, and optimize the accuracy of implant placements. Ganymed Robotics targets a wide range of healthcare facilities, including hospitals and surgical centers, particularly in North America and Europe, where there is a growing demand for innovative orthopedic solutions. The end users of their technologies include orthopedic surgeons and patients undergoing joint replacement procedures, positioning the company as a key player in the evolving landscape of orthopedic care.Ganymed Robotics generates revenue through direct sales of its robotic surgical systems and associated support services to healthcare providers. The transaction structure typically involves partnerships with hospitals and surgical facilities, whereby Ganymed Robotics supplies its technologies along with training and ongoing support. These collaborations may involve contractual agreements that ensure continuous service and updates for users. Pricing models are structured around the specific solutions offered, including flagship robotic systems and their instructional programs. By facilitating these direct business-to-business transactions, Ganymed Robotics positions itself to capitalize on the increasing adoption of robotic technologies in orthopedic surgery, fostering long-term relationships with its client base.In January 2023, Ganymed Robotics SAS raised EUR 1 million in venture debt funding, which will be utilized to develop its surgical robotic assistant for knee arthroplasty (TKA) and to facilitate regulatory and market access programs. The company is also focused on developing more innovative products as part of its growth strategy. Ganymed Robotics seeks to expand its market presence, particularly in North America and Europe, which are key regions for orthopedic technological advancements.

## Funding rounds

- Series B, Jan 4, 2023, $15M — Cap Horn, European Innovation Council
- Series B, Jul 1, 2022, $22M — Credit Mutuel Equity, Cathay Capital, Kurma Partners, BNP Paribas Developpement

## Investors

- Credit Mutuel Equity (https://capitalatlas.ai/funds/credit-mutuel-equity) — Series B
- Cathay Capital — Series B
- Kurma Partners (https://capitalatlas.ai/funds/kurma-partners) — Series B
- BNP Paribas Developpement (https://capitalatlas.ai/funds/bnp-paribas-developpement) — Series B
- Cap Horn (https://capitalatlas.ai/funds/cap-horn) — Series B
- European Innovation Council (https://capitalatlas.ai/funds/european-innovation-council) — Series B